Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
5430513
Reference Type
Journal Article
Title
Organotin compounds alter endocrine functions of human placental cells
Author(s)
Nakanishi, T; Itoh, N; Utoguchi, N; Tanaka, K
Year
2003
Is Peer Reviewed?
1
Journal
Toxicologist
ISSN:
0731-9193
Volume
72
Language
English
Abstract
Tributyltin (TBT) and triphenyltin (TPT) are known to induce an irreversible sexual abnormality of female neogastropod snails which is termed and quot;imposex and quot;. However, in humans, no studies have investigated disturbances in sexual development and reproductive function as a result of exposure to organotin compounds. The placenta plays a vital role in the maintenance of a pregnancy by delivering oxygen and nutrients from the maternal circulation to the fetus and by returning fetal metabolites to the mother. The placenta also has many crucial endocrine functions such as human chorionic gonadotropin (hCG) production and the aromatization of androgen substrates to estrogens. Thus these placental functions might be at high risk due to the developmental and reproductive toxicology of environmental contaminants which have endocrine-disrupting effects. In the present study, to extend knowledge on the sexual developmental and reproductive toxicity of organotin compounds in humans, we assessed the possible effect of organotin compounds on aromatase activity and hCG secretion by human choriocarcinoma cells. Both TBT and TPT increased levels of hCG secretion and aromatase activity in a dose- and time-dependent fashion following exposure to non-toxic concentration ranges. In addition, these compounds enhanced 8-bromo-cAMP-induced hCG secretion and aromatase activity in JAR cells. TBT caused dose-related increases in steady state mRNA levels of both hCG beta and CYP19 in JAR cells following exposure to non-toxic concentrations of TBT. Our studies suggest that TBT and TPT are potent stimulators of human placental hCG production and aromatase activity in vitro; and the placenta represents a potential target organ for these compounds, whose endocrine-disrupting effects might be the result of local changes in hCG and estrogen concentrations in pregnant women.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity